sol-gel.com - נכסים נקיים למניה בודדת SLGL

Sol-Gel Technologies (SLGL) profitability is constrained by patent disputes and a reliance on external investments. The book value per share illustrates the margin of safety, where the 14.75 metric confirms the current level. Revenues are based on innovative treatments for rosacea and acne, while management focuses on pipeline development and increasing royalty payments from partners.

The diversification of production capacities and strategic raw material reserves of Sol-Gel Technologies (SLGL) ensure high operational resilience and a stable cash flow. This BVPS chart reflects the current net asset value per share in real-time, allowing investors to determine the fundamental margin of safety and assess the real cost of capital relative to market quotes.